Clinical Trial Update: High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating high-titer neutralizing plasma for hospitalized West Nile Fever patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• West Nile Fever

Drugs mentioned

• High-Titer Neutralizing Plasma (convalescent plasma)

Snippet

Sponsor: Gili Regev-Yochay MD | Conditions: West Nile Fever | Phase 2 | Status: RECRUITING